About the Authors
- Laurent Fauchier
-
* E-mail: lfau@med.univ-tours.fr
Affiliation Service de Cardiologie, Centre Hospitalier Universitaire Trousseau and Université François Rabelais, Tours, France
- Nicola Greenlaw
-
Affiliation Robertson Centre, University of Glasgow, Glasgow, United Kingdom
- Roberto Ferrari
-
Affiliation Department of Cardiology, University Hospital of Ferrara and Maria Cecilia Hospital, GVM Care&Research, E.S. Health Science Foundation, Cotignola, Italy
- Ian Ford
-
Affiliation Robertson Centre, University of Glasgow, Glasgow, United Kingdom
- Kim M. Fox
-
Affiliation NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom
- Jean-Claude Tardif
-
Affiliation Montreal Heart Institute, Université de Montreal, Montreal, Canada
- Michal Tendera
-
Affiliation Medical University of Silesia, Katowice, Poland
- Ph. Gabriel Steg
-
Affiliations NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom, Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France, INSERM U-1148, Paris, France, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Assistance Publique—Hôpitaux de Paris, Paris, France
- CLARIFY Investigators
-
¶Membership of the CLARIFY Investigators is provided in the Acknowledgments.
Competing Interests
This study was funded via research grants from Servier. Editorial support was provided by Sophie Rushton-Smith, PhD (MedLink Healthcare Communications). Dr. Fauchier reports consultancy fees/honoraria from Bayer, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb-Pfizer alliance, Medtronic, Novartis, Sanofi, and Servier. Ms Greenlaw reports no relationships. Dr. Ferrari reports Speaker’s bureau for Servier, Roche, Boehringer Ingelheim; research grants from Servier, Boehringer Ingelheim and Roche; and advisory board for Servier, Bayer, Roche and Boehringer Ingelheim. Dr Ford reports research grants, honoraria for committee membership, and support for conference attendance from Servier. Dr. Fox reports fees, honoraria, and research grants from Servier. Dr. Tarif reports research grants and honoraria from Servier. Dr. Tendera reports fees, honoraria, and research grants from Amgen, Bayer, Menarini, Servier and TIMI Group. Dr. Steg reports research grants from Servier; consultancy fees/honoraria from Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo/Eli Lilly alliance, Eisai, GlaxoSmithKline, Medtronic, Merck Sharpe and Dohme, Pfizer, Roche, Sanofi, Servier, and The Medicines Company; and equity ownership in Aterovax. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LF NG RF IF KMF JCT MT PGS. Performed the experiments: LF RF KMF JCT MT PGS. Analyzed the data: NG. Wrote the paper: LF. Provided intellectual input into the writing of the manuscript: NG RF IF KMF JCT MT PGS. Approved the manuscript for submission: LF NG RF IF KMF JCT MT PGS.